FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Rejects Lipocine NDA for Testosterone Drug

FDA issues Lipocine a complete response letter on its NDA for Tlando, an oral testosterone product candidate for testosterone replacement therapy in a...

Federal Register

OTC Labeling Info Collection Extension

Federal Register notice: FDA submits to OMB an information collection extension for Format and Content Requirements for Over-the-Counter Drug Product ...

Human Drugs

Small Pharmacyֺs Role in Ranitidine Concerns

Start-up pharmacy Valisure makes a name for itself by chemically validating drugs it purchases from wholesalers before fulfilling prescriptions for co...

Human Drugs

Firm Sues FDA to Reverse Clinical Hold

Regenxbio files a lawsuit in DC federal court against FDA, challenging a clinical hold on its gene therapy for retinal diseases.

Medical Devices

Breakthrough for AI System for Endoscopy Images

FDA grants AI Medical Service a Breakthrough Device Designation for its artificial intelligence programs that analyze endoscopy images for diagnosing ...

Human Drugs

Allergan Drug Gains Infectious Disease Designation

FDA grants Allergan a Qualified Infectious Disease Product designation and fast track status for ATM-AVI (aztreonam and avibactam) for treating certai...

Human Drugs

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 11/8/2019.

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.

Human Drugs

Aurobindo Recalls Ranitidine Products

FDA says Aurobindo has recalled 38 lots of ranitidine products for unacceptable NDMA levels.

Human Drugs

FDA Approves Celgenes Reblozyl for Some Anemic Adults

FDA approves Celgenes Reblozyl as the first treatment for adults with anemia who have beta thalassemia and require regular red blood cell transfusions...